Skip to main content

Table 3 In-hospital MACE

From: Benefits of successful percutaneous coronary intervention in chronic total occlusion patients with diabetes

 

No Diabetes

Diabetes

p Value

(n = 702)

(n = 374)

MACE, n%

29(4.13)

20(5.35)

0.362

All-cause mortality, n%

4(0.57)

3(0.80)

0.652

Cardiac mortality, n%

4(0.57)

3(0.80)

0.652

Nonfatal MI, n%

12(1.71)

5(1.34)

0.641

Clinically driven revascularization, n%

14(1.99)

13(3.48)

0.139

Emergency PCI

14(1.99)

13(3.48)

0.139

Emergency CABG

0

0

−

  1. MACE major adverse cardiac event, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting